By breaking down fatty acids, GW0742 improves body composition and helps lose weight:
In obese female mice, regular exercise together with GW0742 treatment effectively reduced visceral adipose tissue mass and skeletal muscle inflammation.
In mice, it was shown that GW0742 and phillyrin (an anti-obesity agent) have similar weight-reducing effects.
In obese mice, GW0742 administration resulted in a modest reduction in fat mass.
In obese mice, GW0742 exerted preventive effects against obesity.